These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8621273)

  • 21. Identification of reproducible low mass SELDI protein profiles specific to cisplatin resistance in human ovarian cancer cells.
    Britten RA; Hardy C; Vlahou A; Gregory B; Giri PS; Drake R
    Oncol Rep; 2005 Nov; 14(5):1323-30. PubMed ID: 16211304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of four Chinese herbal extracts on drug-sensitive and multidrug-resistant small-cell lung carcinoma cells.
    Sadava D; Ahn J; Zhan M; Pang ML; Ding J; Kane SE
    Cancer Chemother Pharmacol; 2002 Apr; 49(4):261-6. PubMed ID: 11914903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of doxorubicin-resistant human bladder cancer cell line (BUI-87/ADMR) and its mechanism of multidrug resistance.
    Guo H; Lu G; Xiong X; Dong J; Liu S
    Chin Med J (Engl); 1997 Mar; 110(3):167-72. PubMed ID: 9594332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of drug resistance in hematologic malignancies.
    Dalton WS
    Semin Hematol; 1997 Oct; 34(4 Suppl 5):3-8. PubMed ID: 9408955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overcoming drug resistance in patients with metastatic breast cancer.
    Wong ST; Goodin S
    Pharmacotherapy; 2009 Aug; 29(8):954-65. PubMed ID: 19637949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Countermeasures for resistance to chemotherapeutic agents in lung cancer].
    Hu CP
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Dec; 31(12):886-8. PubMed ID: 19134402
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug resistance in lung cancer.
    Nishio K; Nakamura T; Koh Y; Suzuki T; Fukumoto H; Saijo N
    Curr Opin Oncol; 1999 Mar; 11(2):109-15. PubMed ID: 10188075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can multidrug resistance mechanisms be modified?
    Arceci RJ
    Br J Haematol; 2000 Aug; 110(2):285-91. PubMed ID: 10971383
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of signal transduction in cancer treatment and drug resistance.
    Liem AA; Chamberlain MP; Wolf CR; Thompson AM
    Eur J Surg Oncol; 2002 Sep; 28(6):679-84. PubMed ID: 12359208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of comparative proteomics to identify potential resistance mechanisms in cancer treatment.
    Zhang JT; Liu Y
    Cancer Treat Rev; 2007 Dec; 33(8):741-56. PubMed ID: 17854999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance to chemotherapy: patient variability and cellular heterogeneity.
    Kessler DA; Austin RH; Levine H
    Cancer Res; 2014 Sep; 74(17):4663-70. PubMed ID: 25183790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Advances in hypoxia microenvironment and chemotherapy-resistant of lung cancer].
    Guo Y; Wu M; Zhao J; Li Y
    Zhongguo Fei Ai Za Zhi; 2014 Mar; 17(3):265-8. PubMed ID: 24667266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug resistance in cancer: a perspective.
    Goldie JH
    Cancer Metastasis Rev; 2001; 20(1-2):63-8. PubMed ID: 11831649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosage strategies for delaying resistance emergence in heterogeneous tumors.
    Vakil V; Trappe W
    FEBS Open Bio; 2021 May; 11(5):1322-1331. PubMed ID: 33638275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular and physiologic mechanisms of drug resistance in cancer: an overview.
    Kerbel RS
    Cancer Metastasis Rev; 2001; 20(1-2):1-2. PubMed ID: 11831636
    [No Abstract]   [Full Text] [Related]  

  • 36. Tracking Tumor Resistance: The Early Promise of "Liquid" Cancer Tests.
    Jenks S
    J Natl Cancer Inst; 2016 Sep; 108(9):. PubMed ID: 27628661
    [No Abstract]   [Full Text] [Related]  

  • 37. Resistance to chemotherapy.
    Hofmann J
    Br J Cancer; 2008 Oct; 99(8):1368. PubMed ID: 18781177
    [No Abstract]   [Full Text] [Related]  

  • 38. The extended-MDR phenotype.
    Davey R; Davey M
    Cytotechnology; 1998 Sep; 27(1-3):237-47. PubMed ID: 19002795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance mechanisms in human lung cancer.
    Mattern J; Volm M
    Invasion Metastasis; 1995; 15(3-4):81-94. PubMed ID: 8621273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug resistance in cancer: a multifactorial problem.
    Mattern J
    Anticancer Res; 2003; 23(2C):1769-72. PubMed ID: 12820456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.